TOP HEADLINES
• DPC not to accept Rs 1.39-bn protest payment
• CBI told to probe charges against Mascrenhas
• Charges against Mascrenhas made public
• Steep hike in postal tariffs from June 1
• IT sector to help India leapfrog to high growth
• MSEB files petition with MERC
• Joharis remanded to CBI custody
• Wage ceiling for employees' PF increased
• Enron's woes make power firms anxious
- - More

CORPORATE HEADLINES
• Pidilite FY-01 net profit at Rs 479.50 million
• Jindal Iron FY-01 loss at Rs 965.20 million
• Gesco Corporation FY-01 net at Rs 51.08 mn
• Mirc Electronics FY-01 net down by 35.51%
• Fire at Rallis India Ankleshwar Plant
• Greenshoe option on Satyam ADS
• Pentamedia to merge its 3 subsidiaries
- - More

MARKET REPORT
Market@May 25: Day's report
Software stocks show a good recovery during the second half of the day. Silverline gains 8 per cent. Tata Elxsi hits 16 per cent upper circuit. Reliance remains firm. Grasim and Tata Power in great demand.

DAILY TECHNICALS
Trading strategy for May 28, 2001
Sensex, Infosys, Digital, Zee, Cipla... Check out what you can do on Monday.

FUND FILE
Franklin India Balanced Fund
The fund has adopted a conservative strategy of a less volatile debt portfolio but it would be too early to take a stance on its performance given its brief track record.

Prudential ICICI Growth Fund
Prudential ICICI Growth has delivered a reasonable 24.35 per cent to beat its benchmark index on the back of a diversified yet tech-heavy portfolio.

STOCK TALK
'Market may be vulnerable to a few more shocks'
'We could become a tech superpower in 10 years if our government does a good job,' says Ramesh Shrichand Damani.

SPECIAL REPORT
'How we built Infosys from scratch'
The lessons they learnt along the way are applicable throughout the world, Infosys chairman
N R Narayana Murthy told Wharton School management graduates.

MARKET IMPACT
'MSCI downgrade won't affect market much'
VSNL: Status quo and waiting to go

REPORTS
He promises invincible security
Vijay Takanti's firm is leveraging the fact that the e-signature Act has been cleared by Congress and trying to provide technology that is not available.

Dr Reddy's sees robust drug pipeline
Dr Reddy's Laboratories expects two of its anti-diabetes drugs to enter phase III clinical trials in the last quarter of 2001.

COLUMN
Cracks already in the JPC's gameplan
'Excluding UTI, which has been at the centre of all the controversy connected with the stock market crisis, suggested an outrageous cover up and made a monkey of those who had been baying for an investigation into its activities,' says Sucheta Dalal.

SPECIAL
IT industry woes: layoffs, ban on foreign jaunts, cost-cuts...
Faced with a slowdown, a now-subdued infotech industry is tightening its belt and reining in expenses.

Firms go back on job offers, students panic
Many firms have withdrawn job offers made to students at campus interviews.

THE BUDGET & GOVT POLICIES
The Rediff Budget Special: Full coverage
Rail Budget 2001-2002: Full coverage
Credit Policy 2001-2002: Full coverage
Exim Policy 2001-2002: Full coverage
Economic Survey 2000-2001: Full coverage